Profil bibliographique

Youngil Koh

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

330Publications signalées

17012Citations signalées

3Affiliations récentes

Institutions déclarées

Seoul National University Seoul National University Hospital Korea Pharma (South Korea)

Domaines associés

Multiple Myeloma Research and TreatmentsCancer Genomics and DiagnosticsAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentMyeloproliferative Neoplasms: Diagnosis and Treatment

Publications récentes

2026 articleOpenAlex

Addition of low-dose antithymocyte globulin to post-transplant cyclophosphamide for effective graft-versus-host disease prophylaxis in peripheral blood stem cell transplantation

Dong Hyun Kim, Sin Young Park, Hyunsoo Cho, Ja Min Byun et autres

0 citationsTransplant Immunology

2026 articleOpenAlex

Danburstotug, an anti‐ PD ‐ L1 antibody, in relapsed/refractory extra‐nodal natural killer/T‐cell lymphoma: The phase 2 DISTINKT study

Won Seog Kim, Seok Jin Kim, Jae‐Cheol Jo, Sang Eun Yoon et autres

0 citationsBritish Journal of Haematology

2026 articleOpenAlex

Compressed Spectrotemporal Imaging for Multiplexed Protein and Transcript Detection in Single Cells

Suyeon Shin, Hyo Geun Yun, Tae Won Kim, Sung Joo Lee et autres

0 citationsACS Sensors

Accès ouvert 2026 articleOpenAlex

Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65–75 years: a real-world study

N. Lee, S Kim, Yugyeong Lee, Sin Young Park et autres

0 citationsBlood Research

Accès ouvert 2026 articleOpenAlex

Clonal Hematopoiesis of Indeterminate Potential and Kidney Failure in CKD

Minsang Kim, Sanyeowool An, Hyunjin Ryu, Choonghyun Sun et autres

0 citationsClinical Journal of the American Society of Nephrology

2025 articleOpenAlex

Clinical Outcomes of Low‐Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis

Jun-Gwang Son, Eun‐Jeong Jeong, Hyeon Jae Jo, Chan Mi Lee et autres

1 citationJournal of Medical Virology

Accès ouvert 2025 conference-abstractOpenAlex

Phase I/II study of mezigdomide and elranatamab for relapsed/refractory multiple myeloma patients (MELT-MM): Initial results from part 1

Ja Min Byun, Chang‐Ki Min, Kihyun Kım, Dok Hyun Yoon et autres

1 citationBlood

2025 conference-abstractOpenAlex

Belantamab mafodotin (belamaf) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for patients (pts) with transplant-ineligible (TI) newly diagnosed multiple myeloma (NDMM): A focus on treatment efficacy and management/resolution of ocular events in the Phase 1 dreamm-9 study

Saad Z. Usmani, Michał Mielnik, Aránzazu Alonso Alonso, Al-Ola Abdallah et autres

0 citationsBlood

2025 conference-abstractOpenAlex

Pirtobrutinib in Relapsed/Refractory (R/R) Waldenström macroglobulinemia (WM): Up to 5 years of follow-up from the Phase 1/2 BRUIN study

Chan Y. Cheah, Manish R. Patel, Toby A. Eyre, Wojciech Jurczak et autres

4 citationsBlood

Accès ouvert 2025 articleOpenAlex

Nanoshield‐Assisted Viral Gene Therapy with Induction of Non‐Apoptotic Cell Death and Durable Antitumor Immunity (Adv. Sci. 41/2025)

Soo‐Hwan Lee, Yun‐Kyeong Cho, Seunghwan Bang, Daeun Sung et autres

3 citationsAdvanced Science

Accès ouvert 2025 articleOpenAlex

Clonal Hematopoiesis in Human Disease: An Essential Immunologic Phenomenon in Aging Populations

Youngil Koh

0 citationsKorean Journal of Medicine

Accès ouvert 2025 reviewOpenAlex

Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased Tissue

Youngil Koh, Isak W. Tengesdal, Siddhartha Jaiswal

2 citationsAnnual Review of Pathology Mechanisms of Disease

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.